Clinically applicable inhibitors impacting genome stability
MetadataShow full item record
This item's downloads: 0 (view details)
Prakash, Anu; Garcia-Moreno, Juan; Brown, James; Bourke, Emer (2018). Clinically applicable inhibitors impacting genome stability. Molecules 23 (5),
Advances in technology have facilitated the molecular profiling (genomic and transcriptomic) of tumours, and has led to improved stratification of patients and the individualisation of treatment regimes. To fully realize the potential of truly personalised treatment options, we need targeted therapies that precisely disrupt the compensatory pathways identified by profiling which allow tumours to survive or gain resistance to treatments. Here, we discuss recent advances in novel therapies that impact the genome (chromosomes and chromatin), pathways targeted and the stage of the pathways targeted. The current state of research will be discussed, with a focus on compounds that have advanced into trials (clinical and pre-clinical). We will discuss inhibitors of specific DNA damage responses and other genome stability pathways, including those in development, which are likely to synergistically combine with current therapeutic options. Tumour profiling data, combined with the knowledge of new treatments that affect the regulation of essential tumour signalling pathways, is revealing fundamental insights into cancer progression and resistance mechanisms. This is the forefront of the next evolution of advanced oncology medicine that will ultimately lead to improved survival and may, one day, result in many cancers becoming chronic conditions, rather than fatal diseases.
Showing items related by title, author, creator and subject.
Short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin compared with sitagliptin in a real-world setting Shao, YL; Yee, KH; Koh, SK; Wong, YF; Yeoh, LY; Low, S; Sum, CF (Singapore Medical Journal, 2017-10-12)INTRODUCTION We aimed to evaluate the effectiveness and safety of canagliflozin as compared to sitagliptin in a real-world setting among multiethnic patients with Type 2 diabetes mellitus (T2DM) in Singapore. METHODS This ...
Kamali, Naghmeh; Aljohani, Marwah; McArdle, Patrick; Erxleben, Andrea (2015-07-14)Ten benzamidinium salts of carboxylic acids, amides, and sulfonamides have been crystallized from solution. Single-crystal X-ray analyses revealed various hydrogen bonding motifs which ate discussed in terms of supramolecular ...
Synthesis of migrastatin and its macroketone analogue and in vivo FRAP analysis of the macroketone on E-Cadherin dynamics Lo Re, Daniele; Zhou, Ying; Nobis, Max; Anderson, Kurt I.; Murphy, Paul V. (Wiley-VCH Verlag, 2014-06-11)An efficient and scalable synthesis of a key acyclic intermediate used for the preparation of migrastatin and its macroketone analogue is described; Brown alkoxyallylation is the key step for this synthesis. The macroketone ...